secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001564590-23-000271
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR reports prelim Q4 sales $64M, FY22 ICL sales $270M; FY23 outlook $340M
----------------------------------------------------------------------------

- Preliminary Q4 net sales ~$64M; FY2022 net sales ~$284M (ICL $270M, other $14M).
- ICL unit growth 20% Q4 Y/Y, 33% FY2022 Y/Y; U.S. ICL units up 109% Q4 Y/Y.
- FY2023 net sales outlook ~$340M, representing ~25% ICL sales growth over FY2022.
- Cash and equivalents ~$225M, up from $120M three years ago.
- Full FY2022 results expected on/about February 22, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000156459023000271/0001564590-23-000271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000156459023000271/staa-8k_20230109.htm
  HTML page:      https://secwatch.observer/filing/0001564590-23-000271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer